DraftKings Ups the Ante in Secondary Offering

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
DraftKings Ups the Ante in Secondary Offering

© Sckrepka / iStock via Getty Images

DraftKings Inc. (NASDAQ: DKNG | DKNG Price Prediction) is moving forward with its secondary offering, but this time it will be upsized from the last announcement. Often, if stock have made incredible runs, the companies will pursue secondary offerings to capitalize on these gains and raise funds to expand the business further.

The DraftKings offering now consists of 40 million shares, with 16 million coming from DraftKings and 24 million offered by certain selling stockholders. Additionally, the underwriters have the option to purchase up to an additional 6 million shares. Previously, the offering was only for 33 million shares, with DraftKings selling 14 million and the selling stockholders offering 19 million.

The company has priced the offering at $40 per share, which would value the total offering size of $1.6 billion.

The underwriters for the offering are Goldman Sachs, Credit Suisse, Morgan Stanley, BofA Securities, UBS Investment Bank, Canaccord Genuity, Cowen, Craig-Hallum and Northland Capital Markets.

DraftKings intends to use the net proceeds it receives from the offering for general corporate purposes.

[nativounit]

Here’s what a few analysts had to say about DraftKings going into the secondary:

  • Craig-Hallum has a Buy rating.
  • Northland Securities has a Buy rating.
  • Oppenheimer has an Outperform rating and a $48 price target.
  • Susquehanna Bancshares has a Buy rating with a $48 price target.
  • Canaccord Genuity’s Buy rating comes with a $50 price target.
  • Cannonball Research has a Buy rating and a $35 price target.
  • Goldman Sachs rates it as Neutral with a $32 price target.

DraftKings stock traded at $41.03 on Friday, in a 52-week range of $9.76 to $44.79. The consensus price target is $43.88.

[recirclink id=714458][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618